Nutriflex Omega Plus 挪威 - 挪威文 - Statens legemiddelverk

nutriflex omega plus

b. braun melsungen ag - glukosemonohydrat / natriumfosfatdihydrat / sinkacetatdihydrat / triglyserider av middels kjedelengde / soyaolje, renset / omega-3-syretriglyserider / isoleucin / leucin / lysinhydroklorid / metionin / fenylalanin / treonin / tryptofan / valin / arginin / histidinhydrokloridmonohydrat / alanin / aspartinsyre / glutaminsyre / glysin / prolin / serin / natriumhydroksid / natriumklorid / natriumacetattrihydrat / kaliumacetat / magnesiumacetattetrahydrat / kalsiumkloriddihydrat - infusjonsvæske, emulsjon

Nutriflex Omega Special 挪威 - 挪威文 - Statens legemiddelverk

nutriflex omega special

b. braun melsungen ag - glukosemonohydrat / natriumfosfatdihydrat / sinkacetatdihydrat / triglyserider av middels kjedelengde / soyaolje, renset / omega-3-syretriglyserider / isoleucin / leucin / lysinhydroklorid / metionin / fenylalanin / treonin / tryptofan / valin / arginin / histidinhydrokloridmonohydrat / alanin / aspartinsyre / glutaminsyre / glysin / prolin / serin / natriumhydroksid / natriumklorid / natriumacetattrihydrat / kaliumacetat / magnesiumacetattetrahydrat / kalsiumkloriddihydrat - infusjonsvæske, emulsjon

Nutriflex Omega Special elektrolytfri 挪威 - 挪威文 - Statens legemiddelverk

nutriflex omega special elektrolytfri

b. braun melsungen ag - glukosemonohydrat / soyaolje, renset / aminosyrer, uspesifisert - infusjonsvæske, emulsjon

Beovu 欧盟 - 挪威文 - EMA (European Medicines Agency)

beovu

novartis europharm limited  - brolucizumab - wet macular degeneration - Øyemidler - beovu er angitt i voksne for behandling av neovascular (våt) aldersrelatert makuladegenerasjon (amd).

Calrecia 100 mmol/ L 挪威 - 挪威文 - Statens legemiddelverk

calrecia 100 mmol/ l

fresenius medical care deutschland gmbh - kalsiumkloriddihydrat - infusjonsvæske, oppløsning - 100 mmol/ l

Prolutex 25 mg 挪威 - 挪威文 - Statens legemiddelverk

prolutex 25 mg

ibsa farmaceutici italia s.r.l. - progesteron - injeksjonsvæske, oppløsning - 25 mg

Vabysmo 欧盟 - 挪威文 - EMA (European Medicines Agency)

vabysmo

roche registration gmbh - faricimab - wet macular degeneration; macular edema; diabetes complications - Øyemidler - vabysmo is indicated for the treatment of adult patients with:neovascular (wet) age-related macular degeneration (namd),visual impairment due to diabetic macular oedema (dme).

Sugammadex Piramal 欧盟 - 挪威文 - EMA (European Medicines Agency)

sugammadex piramal

piramal critical care b.v. - sugammadex sodium - neuromuskulær blokkade - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.

Yesafili 欧盟 - 挪威文 - EMA (European Medicines Agency)

yesafili

viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - Øyemidler - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5. 1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5. 1),visual impairment due to diabetic macular oedema (dme) (see section 5. 1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.

Magnevist 1.88 mg/ ml 挪威 - 挪威文 - Statens legemiddelverk

magnevist 1.88 mg/ ml

bayer ab - solna - dimeglumingadopentetat - injeksjonsvæske, oppløsning - 1.88 mg/ ml